Galmed Pharmaceuticals
GLMD
GLMD
13 hedge funds and large institutions have $3.14M invested in Galmed Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$415K | |
| 2 | +$211K | |
| 3 | +$113K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$66K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
+$41.5K |
Top Sellers
| 1 | -$73K | |
| 2 | -$67K | |
| 3 | -$49K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$17K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$12.1K |